2-methylthio-atp has been researched along with ethidium in 2 studies
| Studies (2-methylthio-atp) | Trials (2-methylthio-atp) | Recent Studies (post-2010) (2-methylthio-atp) | Studies (ethidium) | Trials (ethidium) | Recent Studies (post-2010) (ethidium) |
|---|---|---|---|---|---|
| 265 | 0 | 16 | 4,782 | 11 | 690 |
| Protein | Taxonomy | 2-methylthio-atp (IC50) | ethidium (IC50) |
|---|---|---|---|
| Reverse transcriptase/RNaseH | Human immunodeficiency virus 1 | 2.0333 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cornish, JE; Gargett, CE; Wiley, JS | 1 |
| Cha, SK; Chung, HS; Kong, ID; Lee, JW; Park, KS | 1 |
2 other study(ies) available for 2-methylthio-atp and ethidium
| Article | Year |
|---|---|
ATP, a partial agonist for the P2Z receptor of human lymphocytes.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adenosine Triphosphate; Affinity Labels; Barium; Dose-Response Relationship, Drug; Enzyme Inhibitors; Ethidium; Flow Cytometry; Humans; In Vitro Techniques; Ion Channels; Leukemia, Lymphocytic, Chronic, B-Cell; Linear Models; Lymphocytes; Purinergic P2 Receptor Agonists; Receptors, Purinergic P2; Receptors, Purinergic P2X7; Structure-Activity Relationship; Thionucleotides | 1997 |
ATP-induced [Ca(2+)](i) changes and depolarization in GH3 cells.
Topics: Adenosine Triphosphate; Animals; Calcium; Dose-Response Relationship, Drug; Ethidium; Membrane Potentials; Receptors, Purinergic P2; Receptors, Purinergic P2X7; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Thionucleotides; Tumor Cells, Cultured | 2000 |